Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Genetics, Structure, Function, Mode of Actions and Role in Cancer Development of CYP17

Author(s): Tatyana. A Sushko, Andrei A. Gilep and Sergey A. Usanov

Volume 14, Issue 1, 2014

Page: [66 - 76] Pages: 11

DOI: 10.2174/187152061131300330

Price: $65

Abstract

Most prostate and breast cancers are hormone dependent. The inhibition of steroid 17α-hydroxylase/17,20- lyase (CYP17), which is a crucial enzyme for steroid hormone biosynthesis, is widely used to treat androgen-dependent prostate cancer (PC). CYP17 has dual enzymatic activity: 17alpha-hydroxylase activity (utilizing delta4- C21 steroids as substrates) and the 17,20-lyase activity (using delta5- C21 steroids as substrates). The steroid biosynthetic pathway is directed to either the production of corticosteroids or sex hormones depending on the activity of CYP17. In this review, the current information on the genetics, molecular structure, substrate specificity and inhibitors of CYP17 is analyzed and discussed.

Keywords: Cytochrome P450, CYP17, hormone-dependent cancer, inhibitors of androgen biosynthesis, prostate cancer, steroid hormone biosynthesis, steroid 17α-hydroxylase, 17, 20-lyase.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy